What are your thoughts on the Aphria (APHA) forecast
What’s up with Aphria?
Aphria (APHA) opened at $3.60, which means the stock is up 1.41% from yesterday’s closing price of 3.55. Today, the company has a high of $3.74 and a low of $3.58. The company has a market cap of $957.01 million with a 52-week high of $7.68 and a 52-week low of $1.95.
What about the future for Aphria?
The high forecast for Aphria is 7.20 while the low is 3.50. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Aphria has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information APHA seems to be a safe buy.
Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.